269816/tel-aviv-university-ramot-collaborate-with-bayer-in-testing-drugs-3d-printed-heart-tissue
AMS X

Bayer to Collaborate with Tel Aviv University in Testing Drugs on 3D Printed Heart Tissue

Formnext
RAPID

Share this Article

Researchers have certainly been able to make huge strides over the decades, living and working in the 2D paradigm—along with relying on testing and experimenting using basic devices like the petri dish; however, the ability to engineer and 3D print (or bioprint) tissue has expanded resources for scientists exponentially. Now, Tel Aviv University (TAU), via its technology transfer company Ramot, with Bayer Pharmaceuticals to test drugs on 3D-printed heart tissue.

While there is a long list of the advantages in bioprinting, the ability to cut out experimenting on lab animals is definitely a change for the better too.

“In a petri dish, all the cells line up in 2D, and it’s only one type of cell” said Prof. Tal Dvir of TAU, the scientist responsible for developing the world’s first working 3D printed heart. “In contrast, our engineered tissues are 3D printed, and therefore better resemble real heart tissues,” she added.

The agreement between Bayer and TAU states that their collaboration will involve the development and testing of an in vitro cardiotoxicity platform in Dvir’s Laboratory for Tissue Engineering and Regenerative Medicine. This takes drug testing to a new level—and true reality with tissue engineering.

A 3D-printed, small-scaled human heart engineered from the patient’s own materials and cells. (Photo credit: Tel Aviv University)

“Our printed tissues contain cardiac muscle, blood vessels and the extracellular matrix which connects the different cells biochemically, mechanically and electrically. Moving away from petri dishes to 3D printed tissues could significantly improve drug tests, saving precious time and money with the hope of producing safer and more effective medication,” said Dvir.

“Our end goal is to engineer whole human hearts, including all the different chambers, valves, arteries and veins – the best analogue of this complex organ – for an even better toxicological screening process.”

This new research is, in fact, an extension of previous work using 3D-printed cardiac patches to regenerate hearts in patients suffering from cardiovascular disease. The patches served as a prime example of the potential for patient-specific treatment as the patches were made with fatty tissue removed from the patients themselves.

During the research project, they were also able to 3D print “comprehensive structures,” including an entire heart. Other scientists around the world have produced studies regarding bioprinted heart tissue, novel bioinks, and the development of scaffold-free cardiac constructs.

As researchers expect to be 3D printing patient-specific human organs in the next decade or so, medicine will be transformed as patients no longer have to worry about waiting lists—and dying during that extensive time—or issues with transplant rejection.

Ramot has also recently licensed their technology to Matricelf, a spin-off fabricating patient-specific spinal-cord implants.

[Source / Images: The Jerusalem Post]


Share this Article


Recent News

Bambu Wants to Run Circles Around You

Formnext 2026: Four Booths Not to Miss!



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Axtra3D Rolls Out New Software, Wash and Cure Systems at Formnext 2026

Axtra3D has made a number of strides forward of late, introducing new software workflow tools, a new FR material together with Arkema, and new washing and curing stations. The company...

3D Printing News Briefs, November 14, 2026: Chuck Hull, Tungsten Carbide, Movie Costume, & More

In this weekend’s 3D Printing News Briefs, we are of course starting off with some Formnext news ahead of the big event this coming week. Then we’ll move on to...

Two Farsoon Machine Launches & How Chinese AM OEMs Are Shifting Focus

In posts last month about Eplus3D and how it’s scaling production for the AI infrastructure market, I focused on how the Chinese additive manufacturing (AM) landscape looks poised to intensify...

3D Printing News Briefs, November 11, 2026: Financing, Distributor, Kickstarter, & More

We’re starting off with exciting AMUG news in today’s 3D Printing News Briefs, as Neil Hopkinson was selected for the 2027 Innovators Award. Then we’ll move on to business, with...